title: Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.
authors.affiliation: Department of Medicine, University of the Witwatersrand Medical School, Parktown, Johannesburg, South Africa.
authors.forename: B I
authors.initials: BI
authors.lastname: Joffe
authors.forename: M C
authors.initials: MC
authors.lastname: Kew
authors.forename: V R
authors.initials: VR
authors.lastname: Panz
authors.forename: W J
authors.initials: WJ
authors.lastname: Kalk
authors.forename: R
authors.initials: R
authors.lastname: Shires
authors.forename: J
authors.initials: J
authors.lastname: Wing
authors.forename: H C
authors.initials: HC
authors.lastname: Seftel
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000150:complications*; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy* / Q000209:etiology; D007328:Insulin / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood / Q000150:complications*; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001786:Blood Glucose; D007328:Insulin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D005934:Glucagon; D015282:Octreotide